Kyle A. Raymond

423 total citations
9 papers, 197 citations indexed

About

Kyle A. Raymond is a scholar working on Virology, Epidemiology and Molecular Biology. According to data from OpenAlex, Kyle A. Raymond has authored 9 papers receiving a total of 197 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Virology, 4 papers in Epidemiology and 3 papers in Molecular Biology. Recurrent topics in Kyle A. Raymond's work include HIV Research and Treatment (3 papers), Virus-based gene therapy research (3 papers) and Plant Virus Research Studies (3 papers). Kyle A. Raymond is often cited by papers focused on HIV Research and Treatment (3 papers), Virus-based gene therapy research (3 papers) and Plant Virus Research Studies (3 papers). Kyle A. Raymond collaborates with scholars based in France, United States and Germany. Kyle A. Raymond's co-authors include Bryan R. Cullen, G Ju, Jean‐Nicolas Tournier, Frédéric Iseni, Jean‐Pierre Vartanian, Frédéric Lemoine, Olivier Ferraris, Laetitia Boutin, Rodolphe Suspène and Satish K. Pillai and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Journal of Virology.

In The Last Decade

Kyle A. Raymond

8 papers receiving 180 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kyle A. Raymond France	5	113	72	66	56	44	9	197
Shervin Bahrami Denmark	9	132 1.2×	54 0.8×	28 0.4×	38 0.7×	70 1.6×	25	245
Anna Sloutskin Israel	10	132 1.2×	23 0.3×	149 2.3×	66 1.2×	49 1.1×	16	304
Matthew Urbanowski Canada	3	261 2.3×	74 1.0×	33 0.5×	27 0.5×	53 1.2×	4	331
Ryan C. Donohue United States	11	170 1.5×	85 1.2×	88 1.3×	98 1.8×	48 1.1×	13	313
Tiina Sedman Estonia	10	266 2.4×	31 0.4×	79 1.2×	88 1.6×	30 0.7×	15	349
Kazuyo Yanagiya Japan	6	73 0.6×	32 0.4×	36 0.5×	47 0.8×	229 5.2×	6	302
R.E. Eisenman United States	5	131 1.2×	41 0.6×	53 0.8×	77 1.4×	49 1.1×	5	262
David C. J. Carpentier United Kingdom	10	160 1.4×	39 0.5×	53 0.8×	80 1.4×	25 0.6×	17	306
Lynda Rocheleau Canada	9	117 1.0×	49 0.7×	63 1.0×	17 0.3×	25 0.6×	14	236
Megan Filbin United States	7	314 2.8×	61 0.8×	26 0.4×	24 0.4×	13 0.3×	10	406

Countries citing papers authored by Kyle A. Raymond

Since Specialization

Citations

This map shows the geographic impact of Kyle A. Raymond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle A. Raymond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle A. Raymond more than expected).

Fields of papers citing papers by Kyle A. Raymond

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle A. Raymond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle A. Raymond. The network helps show where Kyle A. Raymond may publish in the future.

Co-authorship network of co-authors of Kyle A. Raymond

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle A. Raymond. A scholar is included among the top collaborators of Kyle A. Raymond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle A. Raymond. Kyle A. Raymond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Suspène, Rodolphe, Kyle A. Raymond, Pablo Guardado‐Calvo, et al.. (2024). Disruption of deoxyribonucleotide triphosphate biosynthesis leads to RAS proto-oncogene activation and perturbation of mitochondrial metabolism. Journal of Biological Chemistry. 301(2). 108117–108117.

Suspène, Rodolphe, Kyle A. Raymond, Laetitia Boutin, et al.. (2023). APOBEC3F Is a Mutational Driver of the Human Monkeypox Virus Identified in the 2022 Outbreak. The Journal of Infectious Diseases. 228(10). 1421–1429. 17 indexed citations

Raymond, Kyle A., Tongcui Ma, Silvana Valdebenito, et al.. (2023). The hypoxia-regulated ectonucleotidase CD73 is a host determinant of HIV latency. Cell Reports. 42(11). 113285–113285. 6 indexed citations

Suspène, Rodolphe, Kyle A. Raymond, Vincent Caval, et al.. (2023). Antagonism of ALAS1 by the Measles Virus V protein contributes to degradation of the mitochondrial network and promotes interferon response. PLoS Pathogens. 19(2). e1011170–e1011170. 3 indexed citations

Raymond, Kyle A., et al.. (2023). The APOBEC3B cytidine deaminase is an adenovirus restriction factor. PLoS Pathogens. 19(2). e1011156–e1011156. 1 indexed citations

Vallejo-Gracia, Albert, Irene P. Chen, Rosalba Perrone, et al.. (2020). FOXO1 promotes HIV latency by suppressing ER stress in T cells. Nature Microbiology. 5(9). 1144–1157. 20 indexed citations

Togarrati, Padma Priya, et al.. (2020). μ‐Lat: A mouse model to evaluate human immunodeficiency virus eradication strategies. The FASEB Journal. 34(11). 14615–14630. 3 indexed citations

Cullen, Bryan R., Kyle A. Raymond, & G Ju. (1985). Functional Analysis of the Transcription Control Region Located Within the Avian Retroviral Long Terminal Repeat. Molecular and Cellular Biology. 5(3). 438–447. 85 indexed citations

Cullen, Bryan R., Kyle A. Raymond, & G Ju. (1985). Transcriptional activity of avian retroviral long terminal repeats directly correlates with enhancer activity. Journal of Virology. 53(2). 515–521. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact